Population pharmacokinetics of intravenous moxifloxacin 400Â mg once-daily dosage in infected patients

The present study developed population pharmacokinetic models for moxifloxacin in infected Chinese patients. The results detailed here could provide a reference for individualized moxifloxacin therapy in the clinical setting.